HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $2,552,000 | -49.9% | 130,290 | -48.2% | 0.01% | -52.2% |
Q4 2017 | $5,091,000 | +180.5% | 251,300 | +140.5% | 0.02% | +155.6% |
Q3 2017 | $1,815,000 | -62.0% | 104,500 | -62.1% | 0.01% | -43.8% |
Q4 2015 | $4,773,000 | +14.8% | 275,400 | -11.0% | 0.02% | -27.3% |
Q3 2015 | $4,157,000 | -60.8% | 309,600 | -34.1% | 0.02% | -65.1% |
Q2 2015 | $10,613,000 | +253.9% | 470,000 | +123.8% | 0.06% | +173.9% |
Q1 2015 | $2,999,000 | +216.7% | 210,000 | +181.9% | 0.02% | +187.5% |
Q1 2014 | $947,000 | -41.6% | 74,500 | -31.1% | 0.01% | -27.3% |
Q4 2013 | $1,622,000 | +20.0% | 108,200 | -11.6% | 0.01% | +266.7% |
Q3 2013 | $1,352,000 | – | 122,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |